{"DataElement":{"publicId":"6692741","version":"1","preferredName":"Adjacent Tumor Histology Type","preferredDefinition":"The type of morphologic characteristics observed by microscope in the tissue next to a benign or malignant tissue growth.","longName":"AJC_TMR_HIST_TP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6690856","version":"1","preferredName":"Adjacent Tumor Histology","preferredDefinition":"Next to or adjoining._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"6690854v1.0:2186387v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"6690854","version":"1","preferredName":"Adjacent Neoplasm","preferredDefinition":"Next to or adjoining.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25408:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjacent","conceptCode":"C25408","definition":"Next to or adjoining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8656B2F7-2DFA-48A0-E053-F662850A4A84","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186387","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B0-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8656B2F7-2E08-48A0-E053-F662850A4A84","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"KNABLEJ","dateModified":"2019-04-25","changeDescription":"4/25/19 jk released/qualified per review by Sarah M. 4/12/19 jk created for PCA Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6690840","version":"1","preferredName":"Lung Biopsy Histology Type","preferredDefinition":"Removal of tissue from the lung, for microscopic examination._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._Something distinguishable as an identifiable class based on common qualities.","longName":"6690840v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Large cell neuroendocrine carcinoma","valueDescription":"Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2838592","version":"1","preferredName":"Large Cell Neuroendocrine Carcinoma","longName":"2838592","preferredDefinition":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A5F1C9-F794-B082-E040-BB89AD436154","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4388-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Carcinoid tumor and atypical carcinoid tumor","valueDescription":"Carcinoid Tumor And Lung Atypical Carcinoid Tumor","ValueMeaning":{"publicId":"6690842","version":"1","preferredName":"Carcinoid Tumor And Lung Atypical Carcinoid Tumor","longName":"6690842","preferredDefinition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A carcinoid tumor of the lung showing focal necrotic changes or a number of mitotic figures between 2 and 10/10 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Neuroendocrine Tumor G2","conceptCode":"C45551","definition":"A neuroendocrine tumor of the lung showing focal necrotic changes or a number of mitotic figures between 2 and 10/10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-4397-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-43B0-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"NUT carcinoma","valueDescription":"Thoracic NUT Carcinoma","ValueMeaning":{"publicId":"6690844","version":"1","preferredName":"Thoracic NUT Carcinoma","longName":"6690844","preferredDefinition":"A highly aggressive, poorly differentiated carcinoma that arises from the thoracic structures. It is characterized by mutations and rearrangement of the NUT gene. It usually presents at an advanced stage with pleuritic chest pain and pleural effusion, non-productive cough, shortness of breath, and weigh loss.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thoracic NUT Carcinoma","conceptCode":"C142781","definition":"A highly aggressive, poorly differentiated carcinoma that arises from the thoracic structures. It is characterized by mutations and rearrangement of the NUT gene. It usually presents at an advanced stage with pleuritic chest pain and pleural effusion, non-productive cough, shortness of breath, and weigh loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-43BD-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-43D6-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Lymphoepithelioma-like carcinoma","valueDescription":"Lung Lymphoepithelioma-Like Carcinoma","ValueMeaning":{"publicId":"6690846","version":"1","preferredName":"Lung Lymphoepithelioma-Like Carcinoma","longName":"6690846","preferredDefinition":"A rare and distinctive type of lung carcinoma characterized by the presence of a syncytial growth pattern, large vesicular nuclei with eosinophilic nucleoli, and dense lymphoplasmacytic infiltration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Lymphoepithelial Carcinoma","conceptCode":"C45519","definition":"A rare and distinctive type of lung carcinoma characterized by the presence of a syncytial growth pattern, large vesicular nuclei with eosinophilic nucleoli, and dense lymphoplasmacytic infiltration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-43E3-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-43FC-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Sarcomatoid carcinoma","valueDescription":"Sarcomatoid Carcinoma","ValueMeaning":{"publicId":"2838764","version":"1","preferredName":"Sarcomatoid Carcinoma","longName":"2838764","preferredDefinition":"Cancer that arises in cells that appear spindle-shaped when viewed under a microscope. These cancers can occur in various places in the body, including the skin, lungs, kidney, breast, gastrointestinal tract, bone, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Carcinoma","conceptCode":"C27004","definition":"A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-12DF-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4406-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Adenosquamous carcinoma","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"4264016","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"4264016","preferredDefinition":"A carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-11A0-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4411-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Large cell carcinoma","valueDescription":"Large Cell Lung Carcinoma","ValueMeaning":{"publicId":"3248491","version":"1","preferredName":"Large Cell Lung Carcinoma","longName":"3248491","preferredDefinition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Large Cell Carcinoma","conceptCode":"C4450","definition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-1764-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"KNABLEJ","dateModified":"2019-04-22","changeDescription":"4/22/19 jk Updated definition to match current NCIt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4426-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Small cell lung cancer (SCLC)","valueDescription":"Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-443B-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Squamous cell carcinoma (SCC)","valueDescription":"Squamous Cell Lung Carcinoma","ValueMeaning":{"publicId":"2956083","version":"1","preferredName":"Squamous Cell Lung Carcinoma","longName":"2956083","preferredDefinition":"A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma","conceptCode":"C3493","definition":"A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B835-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-444F-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Minimally Invasive Adenocarcinoma (MIA)","valueDescription":"Bronchioalveolar Carcinoma","ValueMeaning":{"publicId":"3106712","version":"1","preferredName":"Bronchioalveolar Carcinoma","longName":"3106712","preferredDefinition":"A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D26-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":"Updated definition to match current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4463-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"In situ pulmonary adenocarcinoma (AIS)","valueDescription":"Lung Adenocarcinoma In Situ","ValueMeaning":{"publicId":"6690848","version":"1","preferredName":"Lung Adenocarcinoma In Situ","longName":"6690848","preferredDefinition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma In Situ","conceptCode":"C136486","definition":"A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-4470-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-4489-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Adenocarcinoma (ADC)","valueDescription":"Lung Adenocarcinoma","ValueMeaning":{"publicId":"3106713","version":"1","preferredName":"Lung Adenocarcinoma","longName":"3106713","preferredDefinition":"A carcinoma characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma","conceptCode":"C3512","definition":"A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D4B-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"865699BE-449D-4C43-E053-F662850AB592","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Squamous cell CIS","valueDescription":"Lung Squamous Cell Carcinoma In Situ","ValueMeaning":{"publicId":"6690852","version":"1","preferredName":"Lung Squamous Cell Carcinoma In Situ","longName":"6690852","preferredDefinition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma In Situ","conceptCode":"C136719","definition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8657219C-EA47-1607-E053-F662850AB9A9","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8657219C-EA60-1607-E053-F662850AB9A9","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB6DF9DF-F9F0-65A6-E053-4EBD850A4A2A","beginDate":"2021-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-07","modifiedBy":"ONEDATA","dateModified":"2021-09-07","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB6DF9DF-F9FA-65A6-E053-4EBD850A4A2A","beginDate":"2021-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-07","modifiedBy":"ONEDATA","dateModified":"2021-09-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6690839","version":"1","preferredName":"Lung Biopsy Histology Type","preferredDefinition":"Removal of tissue from the lung, for microscopic examination.:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:Something distinguishable as an identifiable class based on common qualities.","longName":"C51748:C16681:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Biopsy","conceptCode":"C51748","definition":"Removal of tissue from the lung, for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-4356-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"865699BE-4367-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"COLBERTM","dateModified":"2021-09-07","changeDescription":"9/7/21 mr Added Unknown and NR per MCL DD. 4/25/19 jk released/qualified per review by Sarah M.  4/12/19 jk created for PCA Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"},{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"histologic_type","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Adjacent Histology type","type":"Preferred Question Text","description":"Adjacent Histology type","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_2021_08_25-metrics.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"Histologic type","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86994680-81C2-0AF2-E053-F662850ACE6E","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-15","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/7/21 mr Updated PVs, added alt name, AQT, ref doc and Lung Core CSI per MCL DD.  4/25/19 jk released/qualified per review by Sarah M. 4/15/19 jk created for MCL PCA Lung pathology content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}